<DOC>
	<DOCNO>NCT01806415</DOCNO>
	<brief_summary>This randomize , blind , parallel group , placebo-controlled trial 32 evaluable healthy male non-pregnant female , 18-50 year old volunteer . The investigator goal observe pharmacokinetics fenobam oral administration 50 , 100 150 mg group healthy individual compare side effect tolerability single dose fenobam placebo .</brief_summary>
	<brief_title>Pharmacokinetics Side Effects mGlu5 Antagonist Fenobam Adult Healthy Volunteers</brief_title>
	<detailed_description>Treatment regimen 1 : Fenobam [ 1- ( 3-chlorophenyl ) -3- ( 1-methyl-4-oxo-2-imidazolidinylidine ) urea hydrate ] , oral administration one 50 mg gelatin capsule . Treatment regimen 2 : Fenobam , oral administration one 100 mg gelatin capsule . Treatment regimen 3 : Fenobam , oral administration one 150 mg gelatin capsule . Treatment regimen 4 : Placebo ( lactose ) , oral administration one 150 mg gelatin capsule .</detailed_description>
	<criteria>Inclusion Criteria 1 . 1850 yr old 2 . Good general health remarkable medical condition ( e.g liver , kidney , heart , lung failure ) , BMI &lt; 33 know drug allergy . 3 . Willing comply study guideline outline protocol 4 . Willing provide inform consent . Exclusion Criteria 1 . Medication use ( prescription non prescription medication , vitamin , herbal , dietary mineral supplement grapefruit product within 14 day prior study participation ; excludes contraceptive ) 2 . History addiction drug alcohol ( prior present addiction treatment addiction ) 3 . Pregnant nursing female 4 . Lactose intolerance 5 . Smokers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Fenobam ,</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>side effect</keyword>
</DOC>